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Olfactomedin proteins are characterized by a conserved domain of ∼250 amino acids
corresponding to the olfactomedin archetype first discovered in olfactory neuroepithelium.
They arose early in evolution and occur throughout the animal kingdom. In mice and
humans olfactomedin proteins comprise a diverse array of glycoproteins, many of which
are critical for early development and functional organization of the nervous system as well
as hematopoiesis. Olfactomedin domains appear to facilitate protein-protein interactions,
intercellular interactions, and cell adhesion. Several members of the family have been
implicated in various common diseases, notably myocilin in glaucoma and OLFM4 in
cancer. This review highlights this important, hitherto understudied family of proteins.
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INTRODUCTION
In the early 1990s, an abundant glycoprotein was discovered
as a contaminant in chemosensory dendritic cilia prepara-
tions purified from olfactory epithelium of the bullfrog, Rana
catesbeiana (Snyder et al., 1991). This protein is secreted into
the nasal lumen, where it forms disulfide linked aggregates,
which are localized to the lower mucus layer in intimate con-
tact with chemosensory dendritic cilia (Bal and Anholt, 1993;
Figure 1). Based on its distinct localization, it was named “olfac-
tomedin” and hypothesized to serve as a differentiation sig-
nal for dendritic knobs of chemosensory neurons, which are
replaced throughout adult life from stem cells in the base
of the olfactory neuroepithelium (Snyder et al., 1991; Bal
and Anholt, 1993; Yokoe and Anholt, 1993). This hypoth-
esis has not yet been experimentally validated, but remains
plausible, especially in the context of neurodevelopmental
functions associated with related proteins, described in this
review.
Olfactomedin was initially considered unique to olfactory neu-
roepithelium, but soon after its discovery alternatively spliced
variants of a homolog—known initially as the AMZ pro-
tein, neuronal olfactomedin, and later as noelin—were found
widely distributed throughout the rat brain and adrenal medulla
(Danielson et al., 1994). The proteins from frog and rat show
extensive homology, with conserved cysteines, including a CXC
motif near the N-terminus, and six evenly distributed N-
glycosylation sites at similar positions (Karavanich and Anholt,
1998). Biochemical studies with lectins and monoclonal anti-
bodies showed evidence for intramolecular and intermolecular
disulfide bonds, which enable the formation of homopolymers
(Snyder et al., 1991; Figure 1). Subsequently, a vast number of
proteins that share an ∼250 amino acid domain homologous
to olfactomedin and thought to mediate protein-protein inter-
actions were discovered in animals ranging from nematodes to
people (Zeng et al., 2005).
Olfactomedins appear to be critical mediators for develop-
ment, including early development of the nervous system and
hematopoiesis, and disruption of their expression results in dra-
matic developmental perturbations and lethality. Recapitulation
of embryonic expression of some olfactomedin-domain proteins
in adult life has been implicated in a variety of prevalent diseases,
including glaucoma and cancer—most notably gastrointestinal
cancers.
THE OLFACTOMEDIN PROTEIN FAMILY
Comprehensive phylogenetic analyses have categorized
olfactomedin-domain proteins into seven subfamilies, designated
with Roman numerals I through VII (Zeng et al., 2005; Figure 2).
This classification used amassin, an olfactomedin-domain protein
found in sea urchin (Hillier and Vacquier, 2003), as an outgroup.
The identification of four additional sea urchin amassins, suggest
that these olfactomedin-domain proteins should be considered a
separate family, bringing the total number of subfamilies to eight
(Hillier et al., 2007; Figure 2). Olfactomedin domains across all
families show extensive sequence similarities, with signal pep-
tides and invariant DExGLW and CG sequences in addition to
cysteines and N-glycosylation sites shared among many members
of the family at corresponding positions (Zeng et al., 2005). With
the exception of subfamilies II and VI, olfactomedin domains are
located at C-terminal regions. The original protein isolated from
olfactory epithelium is amember of subfamily V and consists only
of the canonical olfactomedin sequence. The most extensively
studied member of the olfactomedin protein family is myocilin,
which belongs to subfamily III, and is associated with glaucoma.
OLFACTOMEDINS AS MEDIATORS OF DEVELOPMENT
ROLE OF OLFACTOMEDINS IN DEVELOPMENT AND FUNCTIONAL
ORGANIZATION OF THE NERVOUS SYSTEM
Following the discovery of an olfactomedin homolog in the rat
brain (Danielson et al., 1994), a screen of a cDNA library derived
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FIGURE 1 | Olfactomedin from the bullfrog. (A) A model for the structure
of olfactomedin based on biochemical and immunochemical studies. There
are six N-glycosylated carbohydrate attachment sites, two internal disulfide
bonds, and two cysteines, including the CXC motif near the N-terminus that
can form intermolecular disulfides, which mediate the formation of oligomers
through alternating single and double disulfide bonds. Disulfide bonds are
shown in orange and the green rectangular boxes represent carbohydrate
moieties (modified from Yokoe and Anholt, 1993). (B) Immunohistochemical
localization of olfactomedin at the surface of the olfactory neuroepithelium of
Rana catesbeiana. Granular staining of brown horseradish peroxidase
reaction product can be seen in the sustentacular cells, and olfactomedin
deposits are evident at the surface, where they associate with olfactory
dendritic cilia (from Snyder et al., 1991). (C) Immunohistochemical localization
of olfactomedin in acinar cells of Bowman’s glands of the olfactory epithelium
of Rana catesbeiana. The left panel shows brown horseradish peroxidase
reaction product visualized with an antibody that recognizes the fully
glycosylated protein, whereas the non-glycosylated precursor is detected by
a different antibody in perinuclear regions of the acinar cells, shown in the
right panel. The asterisks label the nuclei of acinar cells and L designates the
lumen (from Bal and Anholt, 1993).
from quail neural crest and neural tube led to the identifica-
tion of a similar protein (Barembaum et al., 2000). This protein
showed a distinct expression gradient with highest expression
in the neural fold region and lower expression at the ventral
midline that correlated with closure of the neural tube dur-
ing chick embryogenesis. It was named “noelin” based on the
acronym “neuronal olfactomedin-related endoplasmic reticulum
localized.” Retrovirus mediated overexpression of this protein
promoted neural crest cell emigration and expanded the time
span during which neural crest cells could emerge from the neural
tube (Barembaum et al., 2000). Thus, studies on noelin provided
the first direct evidence for a function of an olfactomedin-domain
protein in neurogenesis.
A further study in Xenopus showed that the effects of an
alternative splice form of noelin, noelin-1, extend beyond the
formation of the neural crest and also impacts later stages of
neural development (Moreno and Bronner-Fraser, 2001). Noelin
is produced as four alternatively spliced isoforms which are dif-
ferentially expressed at different developmental stages. One of
those isoforms, noelin-4, inhibits differentiation of neural precur-
sors, limiting the appearance of differentiated neurons even as the
pool of neural precursors expands. The effects of noelin-4 could
be counteracted by co-expression of noelin-1 and interactions
between these isoforms may be critical for regulating the tim-
ing of neural differentiation during development (Moreno and
Bronner-Fraser, 2005).
An additional member of the olfactomedin protein family in
Xenopus, tiarin, has also been implicated in early formation of
the nervous system (Tsuda et al., 2002). Unlike noelin, tiarin is
expressed in non-neural head ectoderm that flanks the neural
plate at the neurula stage of development and promotes dor-
salization of the neural tube. Overexpression of tiarin results in
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FIGURE 2 | Overview of the olfactomedin protein family. The upper
diagram highlights examples of olfactomedin proteins in each category
focusing on proteins that are described in this review. The lower
diagram shows a neighbor joining tree for some representative
members of the family with diagrammatic representations of protein
domains, indicating the olfactomedin homology domain in blue,
collagen-like domains in orange, IgG-like domains in yellow,
transmembrane domains in red, and the leucine zipper region in
myocilin in green. Signal peptides and coiled-coil motifs in some
members of the family, such as amassin, are not indicated. For
complete phylogenetic analyses of the large superfamily of olfactomedin
proteins, see Zeng et al. (2005) and Hillier et al. (2007).
induction of dorsal markers at the expense of ventral markers in
the anterior central nervous system. The molecular mechanisms
of action of noelin and tiarin remain to be determined, but ini-
tial studies on tiarin suggest that its action is independent of bone
morphogenetic protein (BMP) or Sonic hedgehog (Shh) signal-
ing associated with dorsalization and ventralization, respectively
(Tsuda et al., 2002).
Similar neurodevelopmental functions of olfactomedin pro-
teins have been observed in zebrafish. Overexpression studies
and inhibition of protein expression by injection of morpholino
antisense oligonucleotides in embryos showed that the zebrafish
homolog of noelin, designated zebrafish olfactomedin 1, has
profound effects on eye development, including eye size, the
projection field of retinal ganglion cells to the optic tectum,
and extension and branching of retinal ganglion cell axons
(Nakaya et al., 2008). Co-immunoprecipitation experiments
demonstrated a physical interaction between zebrafish olfac-
tomedin 1 and WIF-1, a secreted inhibitor of the Wnt signaling
pathway, suggesting that the effects of zebrafish olfactomedin 1
may be mediated through modulation of Wnt signaling (Nakaya
et al., 2008). Further studies showed that zebrafish olfactomedin 1
promotes axon growth by activating the NogoA receptor complex
(Nakaya et al., 2012).
Similarly, inhibition of protein expression of a second olfac-
tomedin protein in zebrafish, zebrafish olfactomedin-2, by mor-
pholino antisense oligonucleotides resulted in dramatic effects on
development of the anterior central nervous system with cranio-
facial malformations attributable to perturbed differentiation of
cranial neural crest cells (Lee et al., 2008; Figure 3), not unlike
the effects of noelin and tiarin observed in Xenopus (Moreno
and Bronner-Fraser, 2001; Tsuda et al., 2002). The olfactory pits
and eyes were poorly developed, with the latter tending toward
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FIGURE 3 | Effect of olfactomedin 2 gene silencing on development of
the nervous system in zebrafish. Panels (A,C) show a 54hpf normal
embryo injected with a control morpholino-oligonucleotide that expresses
GFP under the control of the Islet-1 promoter labeling the spinal cord and
cranial nuclei. The inset in panel (C) shows axonal projections from spinal
cord motor neurons and neatly aligned cell bodies of Rohon-Beard neurons.
Panels (B) and (D) show embryos at the same stage injected with 5 ng of a
morpholino-oligonucleotide that silences expression of the zebrafish
olfactomedin 2 gene. Note the complete absence of anterior spinal cord
motor neurons [bracketed area in panel (B) and inset in panel (D)] and
jumbled locations of cell bodies of the Rohon-Beard neurons [inset in panel
(D)]. Deformations of the head are also evident (red arrow). See also Lee
et al. (2008).
cyclopia, and the size of the optic tectum was greatly reduced.
Rohon-Beard neurons in the anterior spinal cord appeared dis-
organized and axon guidance of branchiomotor neurons was
disrupted (Lee et al., 2008; Figure 3).
In addition to mediating early stage neurogenesis,
olfactomedin-domain proteins appear essential for enabling
neural signal propagation. Elegant studies on rat dorsal root
ganglion cell cultures showed that gliomedin, an olfactomedin-
domain protein produced by Schwann cells, is essential for the
formation of nodes of Ranvier and the clustering of voltage-
dependent sodium channels during myelination (Eshed et al.,
2005). Gliomedin is a transmembrane protein, which belongs
to subfamily VI of the olfactomedin protein family (Figure 2).
This family encompasses several invertebrate olfactomedin
proteins, including the Drosophila CG6867 gene product and
the Caenorhabditis elegans UNC-122 protein (Zeng et al., 2005).
These proteins are transmembrane proteins, which contain an
extracellular olfactomedin domain along with collagen domains
and are also referred to as “colmedins” (Loria et al., 2004).
Proteolytic cleavage of gliomedin results in the release of a
secreted extracellular fragment containing the olfactomedin
domain (Eshed et al., 2007). This fragment undergoes homo-
oligomerization, becomes integrated in the extracellular matrix
in association with heparin sulfate proteoglycans, and binds
to axonal Nr-CAM and fibronectin type III-like domains of
neurofascin (Eshed et al., 2007; Labasque et al., 2011). This
interaction is essential for the molecular assembly of the nodes
of Ranvier (Figure 4). RNAi-mediated suppression of gliomedin
expression prevents clustering of sodium channels, ankyrin G,
and βIV spectrin, essential for the formation of nodes of Ranvier.
FIGURE 4 | Diagrammatic illustration of the hypothetical action of
gliomedin at the nodes of Ranvier. The olfactomedin domain of
gliomedin, shown in black, interacts with neurofascin (gray half-moon
shapes), while the collagen domain containing region of the molecule,
shown in brown, is integrated in the extracellular matrix (blue).
Voltage-dependent sodium channels at the nodes of Ranvier are shown in
red. Green triangles represent ankyrin G, which links the channel proteins
to βIV spectrin (purple), which is part of the axonal cytoskeleton underneath
the nodes of Ranvier. See also Eshed et al. (2005).
The soluble olfactomedin domain alone appears to be sufficient
to induce the formation of the nodes (Eshed et al., 2005).
Olfactomedin proteins are also implicated in synaptic stability.
The UNC-122 protein in C. elegans is expressed postsynaptically
at muscle synapses (Loria et al., 2004). Examination of unc-122
mutants reveals abnormal sprouting of motor axons and locomo-
tor defects, which become progressively worse as the animal ages.
It has been proposed that UNC-122 is necessary for stabilizing
synaptic transmission at the neuromuscular junction (Loria et al.,
2004).
Similar indications of a trans-synaptic function for olfac-
tomedin proteins come from the class II proteins, which includes
the family of latrophilins (Matsushita et al., 1999; Figure 2).
Latrophilin-1, also known as “calcium-independent receptor of
α-latrotoxin (CIRL)” binds α-latrotoxin, a component of black
widow spider venom, which results inmassive exocytosis of presy-
naptic vesicles (Lelianova et al., 1997; Krasnoperov et al., 1999).
Latrophilins are G-protein coupled receptors with an extracellu-
lar olfactomedin domain near the N-terminus. The olfactomedin
domain is not necessary for α-latrotoxin mediated neurotrans-
mitter release (Krasnoperov et al., 1999), but binds with high
affinity to the presynaptic transmembrane adhesion molecule,
neurexin (Boucard et al., 2012). Although the precise significance
of this trans-synaptic bridging is not clear, it is reminiscent of
the effects of the C. elegans UNC-122 protein at the neuromus-
cular synapse (Loria et al., 2004) and the effect of gliomedin in
stabilizing nodes of Ranvier (Eshed et al., 2005).
Thus, a variety of olfactomedin proteins are associated with
early differentiation of the nervous system as well as maintenance
of neuronal stability. It appears that the former function is medi-
ated primarily through secreted olfactomedin proteins, whereas
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the latter involves membrane-associated proteins with extracel-
lular olfactomedin domains. Studies to date support the notion
that olfactomedin domains mediate protein-protein interactions
that serve to guide, establish, or maintain intercellular connectiv-
ity. The currently available information, however, represents only
the tip of a slowly emerging iceberg. It remains yet to be deter-
mined precisely how temporal and spatial expression of different
olfactomedin proteins is controlled, who all the possible interact-
ing partners are for different members of this family, and which
cellular pathways are triggered by these interactions.
HUMAN OLFACTOMEDIN PROTEINS
Both mouse and human olfactomedin protein families consist
of 13 gene products. A survey of 16 human tissues with probes
corresponding to five olfactomedin-related proteins, OLFM1-
OLFM4 (also designated as hOlfA-hOlfD) and myocilin, showed
widespread and strikingly tissue-specific expression patterns
(Kulkarni et al., 2000). OLFM1 and OLFM3 are neuronal olfac-
tomedin proteins, with OLFM1 corresponding to the rat neu-
ronal olfactomedin found throughout the brain and OLFM3, also
known as optimedin (Torrado et al., 2002), expressed in cerebel-
lum (Kulkarni et al., 2000) and in the eye (Torrado et al., 2002).
In addition to its expression in brain, OLFM1 is also expressed
in embryonic heart and has been implicated in heart develop-
ment (Lencinas et al., 2013). OLFM2 is expressed in pancreas
and prostate, and OLFM4 in colon, small intestine, and prostate
(Kulkarni et al., 2000; Figure 5).
In addition to their role in neural development, olfactomedin
proteins appear associated with immunity. Amassin in sea urchin
and an olfactomedin homolog in C. elegans are expressed by
coelomocytes, which fulfill an immune protective function in
the body cavity (Hillier and Vacquier, 2003; Loria et al., 2004).
Among human olfactomedins, such function seems to have been
adopted by OLFM4, which in addition to its expression in the
intestine and prostate is also expressed in bone marrow (Zhang
et al., 2002). Here, pluripotent hematopoietic stem cells dif-
ferentiate either via the lymphoid lineage into B- and T-cell
derived lymphocytes or via the myeloid lineage into erythrocytes,
granulocytes, macrophages, and platelets. OLFM4 (also desig-
nated GW112 or hGC-1, human Granulocyte Colony stimulating
factor clone 1) is expressed during stem cell differentiation only
in the myeloid lineage, where it becomes restricted to expres-
sion in granulocytes (Zhang et al., 2002; Rosenbauer et al., 2004).
OLFM4 expression in myeloid precursor cells is controlled by
phosphatidyl inositol 3 kinase and the ERK1/2 mitogen acti-
vated kinase pathway that activate the NF-κB transcription factor,
which binds to a promoter site in the 5′-upstream region of
the OLFM4 gene (Chin et al., 2008). The precise function of




The most extensively studied olfactomedin protein to date is
myocilin, which was first discovered in human trabecular mesh-
work cells (Stone et al., 1997). The trabecular meshwork is a
connective tissue that regulates outflow at the iridocorneal angle
of the eye and, hence, controls intraocular pressure. Ocular hyper-
tension is a major risk factor for glaucoma, which results in
progressive degeneration of the optic nerve. Diabetes mellitus
is also known to confer risk for glaucoma and is accompa-
nied by high circulating levels of the stress hormone cortisol. A
major breakthrough in attempts to understand the etiology of
glaucoma was the discovery that administration of cortisol to pri-
mary cell cultures of human trabecular meshwork cells resulted
in pronounced overexpression of a protein, initially designated
“trabecular meshwork inducible glucocorticoid response (TIGR)
protein,” but more commonly known as “myocilin” (Stone et al.,
1997; Clark et al., 2001).
Myocilin is a member of the olfactomedin protein family. It is
a secreted glycoprotein that contains a C-terminal olfactomedin
domain and an N-terminal leucine zipper motif (Nguyen et al.,
1998). Mutations in its olfactomedin domain have been associ-
ated with more than 10% of cases of juvenile onset glaucoma
FIGURE 5 | Tissue-specific expression of OLFM4. A radiolabeled oligonucleotide probe was hybridized to a Northern blot containing mRNA from human
tissue samples. Note the specific expression of OLFM4 (arrowhead) in prostate, small intestine, and colon (arrows). Modified from Kulkarni et al. (2000).
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and ∼4% of cases of adult onset primary open angle glaucoma
(Adam et al., 1997; Stone et al., 1997; Wiggs et al., 1998). Such
association studies have been conducted and replicated in at least
a dozen populations across the globe, making the association
between myocilin polymorphisms and glaucoma risk one of the
best consolidated relationships in human disease genetics (Anholt
and Carbone, 2013). The importance of these discoveries cannot
be overstated, as they provided the first insight into the molecular
basis of a disease that on average affects 1 out of 100 individuals
over the age of 40, with an even higher incidence among indi-
viduals of African and Hispanic descent (Quigley and Broman,
2006).
The myocilin gene consists of 3 exons and a 5-kb promoter
region that contains 13 predicted hormone response elements,
including glucocorticoid regulatory elements, and several addi-
tional regulatory motifs that point at complex regulation of its
expression (Nguyen et al., 1998). Following translation, myocilin
is cleaved in the endoplasmic reticulum by the calcium-dependent
endoprotease calpain II at residues that link its leucine zip-
per motif and the C-terminal olfactomedin domain (Sánchez-
Sánchez et al., 2007).
The function of myocilin is not known. There is evidence that
myocilin can interact with optimedin (OLFM3), which is co-
expressed with myocilin in trabecular meshwork and retina, and
which is, based on its sequence, more closely related to noelin
than myocilin (Torrado et al., 2002). Co-immunoprecipitation
experiments demonstrated a direct interaction between these two
secreted olfactomedin proteins (Torrado et al., 2002). Expression
of optimedin, however, appears to be independent of glucocor-
ticoids. Rather, the Pax6 transcription factor has been impli-
cated in the regulation of optimedin expression (Grinchuk et al.,
2005). In line with the cell adhesion properties of closely related
olfactomedin proteins, optimedin promotes aggregation of NGF-
stimulated PC12 cells and induces expression of N-cadherin (Lee
and Tomarev, 2007). It is, therefore, conceivable that myocilin,
either by itself or as a complex with optimedin, stabilizes intercel-
lular interactions.
Based on the context with other olfactomedin proteins that
mediate development of the nervous system, one can speculate
that myocilin plays a role in development of eye structures and
that recapitulation of excessive expression of myocilin under con-
ditions of stress during adulthood has pathological consequences.
A developmental function for myocilin is supported by evidence
that myocilin may modulate Wnt signaling (Kwon et al., 2009)
and that myocilin itself or its proteolytic fragments promote cell
migration of NIH3T3 and FHL124 cells through activation of
integrin focal adhesion kinase signaling (Kwon and Tomarev,
2011). Similarly, myocilin multimers, but not monomers, pro-
moted substrate adhesion of trabecular meshwork cells in pri-
mary cell cultures (Goldwich et al., 2009).
It is likely that the function of myocilin is unrelated to its rela-
tionship with glaucoma etiology. Truncated myocilin that lacks
the olfactomedin domain and misfolded mutant myocilins with
mutations in the olfactomedin domain are retained in the endo-
plasmic reticulum (Caballero et al., 2000; Gobeil et al., 2006).
The latter also interfere with the secretion of optimedin (Torrado
et al., 2002). It has been proposed that excessive accumulation
of protein aggregates in the endoplasmic reticulum of trabecular
meshwork cells leads to endoplasmic reticulum stress (Carbone
et al., 2009; Anholt and Carbone, 2013). This would activate the
unfolded protein response, a pathway that removes misfolded or
aggregated proteins and processes them for proteolytic degrada-
tion via the proteasome (Hetz, 2012). Failure to accomplish this
task would trigger apoptosis (Figure 6).
There is substantial evidence to support this hypothesis.
Overexpression of human myocilin in the eye of Drosophila
melanogaster results in an ocular hypertension phenotype in
which ommatidia become distended and extrude fluid through
the lenses onto the surface of the eye (Borrás et al., 2003). In
the fly model overexpressed myocilin formed aggregates, and
activation of the unfolded protein response could be visualized
with a fluorescent xbp1-EGFP marker (Carbone et al., 2009).
Subsequently, human homologs of Drosophila genes associated
with the myocilin-induced unfolded protein response were found
to harbor single nucleotide polymorphisms associated with pri-
mary open angle glaucoma in Salt Lake City (UT) and San
Diego (CA) case-control study populations (Carbone et al., 2011).
Replicate polymorphisms were identified in PDIA5 and BIRC6.
PDIA5 encodes a protein disulfide isomerase that forms disul-
fide bonds during protein folding (Kozlov et al., 2010), whereas
BIRC6 encodes an ubiquitin ligase that tags misfolded proteins
for proteolytic degradation (Bartke et al., 2004).
There is additional independent support for involvement of
the unfolded protein response pathway as a central mechanism
for the pathogenesis of glaucoma. Accumulation of Y437H-
myocilin, a mutant myocilin that causes severe glaucoma in
people, in the endoplasmic reticulum of transgenic mice leads
to activation of the apoptotic pathway and results in a glaucoma
phenotype (Zillig et al., 2005; Zhou et al., 2008). Endoproteolytic
FIGURE 6 | Diagram of myocilin-induced endoplasmic reticulum stress
and apoptosis. Overexpression of myocilin results in the formation of
aggregates in the endoplasmic reticulum (ER) and activation of the unfolded
protein response (UPR). If accumulation of myocilin aggregates exceeds
the capacity of the unfolded protein response the apoptotic pathway is
activated. Jagged shapes represent the N-terminal domain of myocilin with
leucine zipper motifs.
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cleavage of myocilin by calpain II prevents its aggregation and
it has been suggested that misfolded mutant forms of myocilin
render the calpain II cleavage site inaccessible, thereby enabling
protein accumulation (Aroca-Aguilar et al., 2005).
In addition to its expression in the eye, myocilin is also found
in skeletal muscle and heart (Kulkarni et al., 2000). Interestingly,
no deficits in cardiac or muscle function have been reported
for individuals carrying mutant myocilins that predispose to
glaucoma.
OLFACTOMEDINS AND CANCER
The role of olfactomedin proteins in cell adhesion and differen-
tiation makes it intuitively plausible that they might function in
cancer. Although no causal link has been demonstrated between
altered expression of olfactomedin proteins and cancer, correla-
tions between expression of OLFM4 (Figure 5) and cancer have
been well documented. In addition to OLFM4, OLFM1 has been
implicated in lung adenocarcinoma (Wu et al., 2010) and OLFM3
in endothelioma (Miljkovic-Licina et al., 2012), where it has been
proposed to bind to BMP4 and enhance SMAD1/5/8 signaling
required for BMP4-induced angiogenesis (Miljkovic-Licina et al.,
2012). However, at present evidence for roles of OLFM1 and
OLFM3 in cancer is scarce and needs to be further consolidated.
Most studies to date have focused on OLFM4, which has been
associated with some of the most prevalent malignancies, includ-
ing gastric cancer (Oue et al., 2009; Luo et al., 2011; Yu et al.,
2011a; Liu et al., 2012), pancreatic cancer (Kobayashi et al., 2007;
Chen et al., 2011), colon, lung and breast cancer, colorectal ade-
nomas and liver metastases of colorectal origin (Seko et al., 2010;
Besson et al., 2011; Sentani et al., 2013), endometriosis (Dassen
et al., 2010), and cervical cancer (Yu et al., 2011b). Increased
serum levels of OLFM4 have been proposed as diagnostic mark-
ers of early stages of gastric cancer and colorectal cancer (Oue
et al., 2009; Grover et al., 2010; Seko et al., 2010; Yu et al.,
2011a). In a study on 176 colorectal cancer patients, those in
which positive cytoplasmic immunohistochemical staining for
OLFM4 was observed had better survival rates than those who
showed negative staining, suggesting that OLFM4 could serve as
a potential prognostic marker for long term survival of colorectal
cancer patients (Seko et al., 2010). OLFM4 expression is also up-
regulated in gastric biopsies of patients with Helicobacter pylori
infection and inflammatory bowel disease (Liu et al., 2010a). It
is not clear to what extent up-regulation of OLFM4 under these
conditions directly contributes to disease manifestation.
Human OLFM4 shows 65% amino acid identity to the canon-
ical olfactomedin from olfactory epithelium of the bullfrog and
like the frog olfactory protein is a secreted glycoprotein with
six N-glycosylation sites (Grover et al., 2010). Like frog olfac-
tomedin, OLFM4 forms large polymers through intermolecular
disulfide bonds via a cysteine at position 226. Its glycoside moi-
eties can bind to lectins on cell surfaces with high affinity (KD =
1.57 × 10−8 M) and co-immunoprecipitation studies on trans-
fected 293 T/17 cells showed that OLFM4 interacts with cadherin
via its olfactomedin domain (Liu et al., 2006). Overexpression of
OLFM4 in HT-29 colon carcinoma cells resulted in decreased cell
adhesion and migration. However, OLFM4 gene sequences from
28 colon cancer samples did not show any sequence variants in
a 1 kb promoter region or any of the five exons of the OLFM4
gene, although regulatory polymorphisms in intronic regions or
epigenetic regulation cannot be excluded (Besson et al., 2011).
The normal function of OLFM4 in the gastro-intestinal tract
is not known. The production of OLFM4 in the intestinal lining
may fulfill an immune protective function. OLFM4 is highly
expressed in a subset of pluripotent stem cells in the intestinal
crypts, Lgr5+ cells, which express the Wnt target gene “leucine-
rich repeat containing G-protein coupled receptor 5 (Lgr5)”
(van der Flier et al., 2009). Its expression is here dependent on
Notch signaling concomitant with cell proliferation (VanDussen
et al., 2012). Several studies point at an anti-apoptotic function
for OLFM4 (Liu et al., 2010b, 2012; Yu et al., 2011a), and a
direct physical association between OLFM4 and the apoptotic
protein GRIM-19 (retinoid-interferon-induced-mortality-19)
has been reported (Zhang et al., 2004; Moreira et al., 2011).
In this scenario, prevention of apoptosis by upregulation of
OLFM4 in early stages of malignancy would enable cancer cells
to survive and proliferate. Indeed, overexpression of OLFM4 in
murine prostate cancer cells promoted tumor growth (Zhang
et al., 2004). The physiological significance of an anti-apoptotic
function of OLFM4 under normal conditions, however, needs
to be further consolidated, as the primary role of OLFM4 is
likely extracellular. One can speculate that the tumorigenic
activity of overexpressed OLFM4 is dissociated from its normal
physiological function and could be related to the induction
of endoplasmic reticulum stress in parallel to the proposed
mechanism by which myocilin accumulation may contribute
to the etiology of glaucoma (Anholt and Carbone, 2013). This
speculation presents a testable hypothesis for future studies.
FUTURE CHALLENGES
Since the discovery of the first olfactomedin, a large number of
olfactomedin-domain proteins have been identified. However, a
unifying view for the functions of these proteins and the rationale
for the evolutionary conservation of the olfactomedin domain
have not yet been formulated. It has become increasingly appar-
ent that olfactomedins play essential roles in development and
cell differentiation and that their effects are mediated through
intercellular interactions, sometimes in conjunction with extra-
cellular matrix components. Their expression is tissue-specific
and regulation of their spatial and temporal expression is con-
trolled by diverse transcriptional regulators. Mutations in critical
regions of these proteins, including the olfactomedin domain, and
perturbation of their expression levels are associated with sev-
eral prevalent diseases, including glaucoma and cancer. Several
unresolved questions remain for future studies. First, we need
to determine the full spectrum of binding partners for all mem-
bers of the olfactomedin superfamily. Also, the three-dimensional
structure of the olfactomedin domain remains to be elucidated.
What are the evolutionary forces that result in its evolutionary
conservation, and how does variation within the conserved olfac-
tomedin domain relate to its different binding partners? Our
understanding of the precise mechanisms that regulate tissue-
specific and temporally controlled expression of each of the
olfactomedin proteins is still rudimentary at best and needs to be
further explored. Another central question pertains to the cellular
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sequellae that are triggered by interactions between olfactomedin
proteins and their binding partners. Furthermore, the precise
functions of many olfactomedin proteins remain still unknown
(e.g., the Drosophila melanogaster CG6867 gene product). Finally,
it is important to obtain a comprehensive assessment to what
extent olfactomedin proteins are implicated in developmental
disorders and to what extent variants in specific olfactomedin
protein encoding genes contribute risk for diseases in addition to
glaucoma.
It is likely that further studies might uncover additional
contributions of olfactomedin proteins to diseases. Thus,
this once neglected family of proteins must now be taken
into account in biochemical studies of development and
disease.
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